185 related articles for article (PubMed ID: 9321753)
41. Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity.
Bürgelová M; Kramer HJ; Teplan V; Thumová M; Cervenka L
Kidney Int; 2005 Apr; 67(4):1453-61. PubMed ID: 15780097
[TBL] [Abstract][Full Text] [Related]
42. Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury.
Song K; Stuart D; Abraham N; Wang F; Wang S; Yang T; Sigmund CD; Kohan DE; Ramkumar N
PLoS One; 2016; 11(7):e0159872. PubMed ID: 27467376
[TBL] [Abstract][Full Text] [Related]
43. Pressure natriuresis and renal medullary blood flow in dogs.
Majid DS; Godfrey M; Navar LG
Hypertension; 1997 Apr; 29(4):1051-7. PubMed ID: 9095098
[TBL] [Abstract][Full Text] [Related]
44. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
Vanecková I; Cahová M; Kramer HJ; Husková Z; Skaroupková P; Komers R; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2004; 27(4):203-10. PubMed ID: 15273422
[TBL] [Abstract][Full Text] [Related]
45. Nitric oxide synthase expression in AT2 receptor-deficient mice after DOCA-salt.
Obst M; Gross V; Bonartsev A; Janke J; Müller DN; Park JK; Kärgel E; Luft FC
Kidney Int; 2004 Jun; 65(6):2268-78. PubMed ID: 15149340
[TBL] [Abstract][Full Text] [Related]
46. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.
Mitchell KD; Jacinto SM; Mullins JJ
Am J Physiol; 1997 Aug; 273(2 Pt 2):F246-53. PubMed ID: 9277585
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
Fontes MA; Baltatu O; Caligiorne SM; Campagnole-Santos MJ; Ganten D; Bader M; Santos RA
Physiol Genomics; 2000 Apr; 2(3):137-42. PubMed ID: 11015592
[TBL] [Abstract][Full Text] [Related]
48. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
[TBL] [Abstract][Full Text] [Related]
49. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
Sato Y; Fujita T
Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
[TBL] [Abstract][Full Text] [Related]
50. Altered pressure natriuresis in chronic angiotensin II hypertension in rats.
van der Mark J; Kline RL
Am J Physiol; 1994 Mar; 266(3 Pt 2):R739-48. PubMed ID: 8160866
[TBL] [Abstract][Full Text] [Related]
51. Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27].
Wagner J; Klotz S; Haufe CC; Danser JA; Amann K; Ganten D; Ritz E
J Hypertens; 1997 Apr; 15(4):441-9. PubMed ID: 9211179
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
Suzuki H; Kondo K; Saruta T
Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
[TBL] [Abstract][Full Text] [Related]
53. Collecting duct function in deoxycorticosterone acetate-escaped, normal, and salt-deprived rats. Response to hypervolemia.
Sonnenberg H
Circ Res; 1976 Aug; 39(2):282-8. PubMed ID: 939014
[TBL] [Abstract][Full Text] [Related]
54. Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
Honetschlägerová Z; Sadowski J; Kompanowska-Jezierska E; Maxová H; Táborský M; Kujal P; Červenka L
Hypertens Res; 2023 Oct; 46(10):2340-2355. PubMed ID: 37592042
[TBL] [Abstract][Full Text] [Related]
55. Exaggerated natriuresis in experimental hypertension.
DiBona GF; Sawin LL
Proc Soc Exp Biol Med; 1986 May; 182(1):43-51. PubMed ID: 3960858
[TBL] [Abstract][Full Text] [Related]
56. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL
Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357
[TBL] [Abstract][Full Text] [Related]
57. Renal vascular and tubulointerstitial inflammation and proliferation in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Graciano ML; Mouton CR; Patterson ME; Seth DM; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1858-66. PubMed ID: 17344186
[TBL] [Abstract][Full Text] [Related]
58. Function of the isolated perfused kidneys from young or adult rats with post-DOCA-salt hypertension.
Vanecková I; Kunes J; Jelínek J
Clin Exp Hypertens; 1999 May; 21(4):407-21. PubMed ID: 10369383
[TBL] [Abstract][Full Text] [Related]
59. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
60. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
